(Q71730418)
Statements
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting (English)
J H Levy
R Pifarre
J C Horrow
R Albus
B Spiess
T K Rosengart
J Murray
R E Clark